ARCHIVES

Cancer Groups Criticize FDA For Ignoring Expert Advice.

This article is from The Cancer Letter archive.

Vol. 26 No. 43 | November 24, 2000

Download PDF Visit The Full Archive

Related Articles

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

August 7, 2009

Barnett Kramer Next Director Of NCI Division of Cancer Prevention

July 29, 2011

EORTC Places Same Number on Phase 2-3 Trials As In U.S.

December 12, 1986

U.S. Adults close to Eating “5 A Day” Of Fruits, Vegetables

March 28, 1997

Medicare Cuts Proposed In budget reduction Amendment For FY94

November 19, 1993

NIH Probing: Double Dipping” Allegation

September 4, 1981